| Literature DB >> 22768051 |
Jung Hun Oh1, Harry P Wong, Xiaowei Wang, Joseph O Deasy.
Abstract
The number of biomarker candidates is often much larger than the number of clinical patient data points available, which motivates the use of a rational candidate variable filtering methodology. The goal of this paper is to apply such a bioinformatics filtering process to isolate a modest number (<10) of key interacting genes and their associated single nucleotide polymorphisms involved in radiation response, and to ultimately serve as a basis for using clinical datasets to identify new biomarkers. In step 1, we surveyed the literature on genetic and protein correlates to radiation response, in vivo or in vitro, across cellular, animal, and human studies. In step 2, we analyzed two publicly available microarray datasets and identified genes in which mRNA expression changed in response to radiation. Combining results from Step 1 and Step 2, we identified 20 genes that were common to all three sources. As a final step, a curated database of protein interactions was used to generate the most statistically reliable protein interaction network among any subset of the 20 genes resulting from Steps 1 and 2, resulting in identification of a small, tightly interacting network with 7 out of 20 input genes. We further ranked the genes in terms of likely importance, based on their location within the network using a graph-based scoring function. The resulting core interacting network provides an attractive set of genes likely to be important to radiation response.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22768051 PMCID: PMC3387230 DOI: 10.1371/journal.pone.0038870
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Radio-responsive biomarkers identified by literature review and their biological processes.
| Gene Symbol | Entrez Gene ID | DNA repair | Cell proliferation | Cell cycle | Apoptosis | Response to stress | Reference | ||
| ABCA1 | 19 |
| |||||||
| ABL1 | 25 | v | v | v | v |
| |||
| ACTA2 | 59 |
| |||||||
| AEN | 64782 | v | v |
| |||||
| AKR1B1 | 231 | v |
| ||||||
| AKT1 | 207 | v | v | v |
| ||||
| ALAD | 210 |
| |||||||
| ANXA1 | 301 | v | v | v | v |
| |||
| APEX1 | 328 | v | v |
| |||||
| APOE | 348 | v | v | v |
| ||||
| AR | 367 | v |
| ||||||
| ATF3 | 467 | v |
| ||||||
| ATM | 472 | v | v | v | v | v |
| ||
| BAD | 572 | v | v |
| |||||
| BAK1 | 578 | v |
| ||||||
| BAX | 581 | v |
| ||||||
| BAZ1B | 9031 | v | v |
| |||||
| BBC3 | 27113 | v |
| ||||||
| BCL2 | 596 | v | v | v | v |
| |||
| BCL2L1 | 598 | v | v | v |
| ||||
| BIRC5 | 332 | v | v |
| |||||
| BRCA1 | 672 | v | v | v | v | v |
| ||
| BRCA2 | 675 | v | v | v | v | v |
| ||
| BTG2 | 7832 | v | v | v | v |
| |||
| CAT | 847 | v | v |
| |||||
| CAV1 | 857 | v | v |
| |||||
| CCNB1 | 891 | v | v | v |
| ||||
| CCND1 | 595 | v | v | v |
| ||||
| CCNE1 | 898 | v |
| ||||||
| CCNG1 | 900 | v | v | v |
| ||||
| CD24 | 100133941 | v | v | v |
| ||||
| CD40 | 958 | v | v |
| |||||
| CD68 | 968 |
| |||||||
| CD69 | 969 |
| |||||||
| CD70 | 970 | v | v |
| |||||
| CD83 | 9308 | v |
| ||||||
| CDC20 | 991 | v | v |
| |||||
| CDC6 | 990 | v | v |
| |||||
| CDH2 | 1000 |
| |||||||
| CDK1 | 983 | v | v | v | v |
| |||
| CDK2 | 1017 | v | v |
| |||||
| CDKN1A | 1026 | v | v | v | v |
| |||
| CDKN2A | 1029 | v | v | v | v |
| |||
| CHEK1 | 1111 | v | v | v | v |
| |||
| CLIC1 | 1192 |
| |||||||
| CRYAB | 1410 | v | v |
| |||||
| CSNK2A2 | 1459 | v |
| ||||||
| CXCR4 | 7852 | v | v |
| |||||
| CYP2D6 | 1565 |
| |||||||
| DCN | 1634 | v |
| ||||||
| DDB2 | 1643 | v | v |
| |||||
| DDR1 | 780 |
| |||||||
| DDR2 | 4921 | v |
| ||||||
| DDX17 | 10521 |
| |||||||
| DRAP1 | 10589 |
| |||||||
| DUSP8 | 1850 |
| |||||||
| EGFR | 1956 | v | v | v | v |
| |||
| EGR1 | 1958 | v |
| ||||||
| EGR4 | 1961 | v |
| ||||||
| EI24 | 9538 | v |
| ||||||
| EIF2AK3 | 9451 | v | v |
| |||||
| EPDR1 | 54749 |
| |||||||
| ERBB2 | 2064 | v | v | v |
| ||||
| ERCC1 | 2067 | v | v |
| |||||
| ERCC2 | 2068 | v | v | v | v | v |
| ||
| ERCC4 | 2072 | v | v | v |
| ||||
| ERCC5 | 2073 | v | v | v |
| ||||
| FAS | 355 | v |
| ||||||
| FASLG | 356 | v | v | v |
| ||||
| FDXR | 2232 |
| |||||||
| FGF1 | 2246 | v | v |
| |||||
| FGF2 | 2247 | v | v | v | v |
| |||
| GADD45A | 1647 | v | v | v | v |
| |||
| GBP1 | 2633 |
| |||||||
| GDF15 | 9518 |
| |||||||
| GFER | 2671 | v |
| ||||||
| GRAP | 10750 |
| |||||||
| GSTA1 | 2938 |
| |||||||
| GSTM1 | 2944 |
| |||||||
| GSTP1 | 2950 | v |
| ||||||
| GSTT1 | 2952 |
| |||||||
| H2AFX | 3014 | v | v | v |
| ||||
| HDAC1 | 3065 | v | v | v |
| ||||
| HERC2 | 8924 | v | v | v |
| ||||
| HSP90AB1 | 3326 | v |
| ||||||
| HSP90B1 | 7184 | v | v |
| |||||
| HSPB1 | 3315 | v | v |
| |||||
| HUS1 | 3364 | v | v | v |
| ||||
| ICAM2 | 3384 |
| |||||||
| ID3 | 3399 | v | v | v |
| ||||
| IER5 | 51278 |
| |||||||
| IFNG | 3458 | v | v | v | v |
| |||
| IGF1R | 3480 | v | v |
| |||||
| IGFBP3 | 3486 | v | v |
| |||||
| IL12RB2 | 3595 | v |
| ||||||
| IL17A | 3605 | v | v |
| |||||
| ILK | 3611 | v | v | v |
| ||||
| IRF1 | 3659 |
| |||||||
| JUN | 3725 | v | v | v | v |
| |||
| KRAS | 3845 |
| |||||||
| LIG1 | 3978 | v | v | v |
| ||||
| LIG3 | 3980 | v | v | v |
| ||||
| LIG4 | 3981 | v | v | v | v | v |
| ||
| LOX | 4015 | v |
| ||||||
| LSM7 | 51690 |
| |||||||
| MAD2L2 | 10459 | v |
| ||||||
| MAP3K7 | 6885 | v | v |
| |||||
| MC1R | 4157 | v | v | v |
| ||||
| MCL1 | 4170 | v |
| ||||||
| MCM2 | 4171 | v |
| ||||||
| MDC1 | 9656 | v | v | v |
| ||||
| MDM2 | 4193 | v | v | v |
| ||||
| MGMT | 4255 | v | v | v |
| ||||
| MLH1 | 4292 | v | v | v | v |
| |||
| MMP2 | 4313 | v |
| ||||||
| MMP9 | 4318 | v |
| ||||||
| MPO | 4353 | v | v |
| |||||
| MR1 | 3140 |
| |||||||
| MRE11A | 4361 | v | v | v |
| ||||
| MRPL23 | 6150 |
| |||||||
| MSH2 | 4436 | v | v | v | v |
| |||
| MTHFR | 4524 |
| |||||||
| MTOR | 2475 | v | v |
| |||||
| MYC | 4609 | v | v | v |
| ||||
| NBN | 4683 | v | v | v | v |
| |||
| NEIL1 | 79661 | v | v |
| |||||
| NEK2 | 4751 | v |
| ||||||
| NFKB1 | 4790 | v | v |
| |||||
| NNMT | 4837 |
| |||||||
| NONO | 4841 | v | v |
| |||||
| NOS3 | 4846 | v | v | v |
| ||||
| NOX4 | 50507 | v | v |
| |||||
| NUDT1 | 4521 | v | v |
| |||||
| OGG1 | 4968 | v | v |
| |||||
| PAH | 5053 |
| |||||||
| PAK6 | 56924 |
| |||||||
| PARP1 | 142 | v | v |
| |||||
| PCNA | 5111 | v | v | v |
| ||||
| PER3 | 8863 |
| |||||||
| PHLPP2 | 23035 |
| |||||||
| PHPT1 | 29085 |
| |||||||
| PIK3CA | 5290 | v |
| ||||||
| PIM2 | 11040 | v | v | v |
| ||||
| PLK2 | 10769 | v |
| ||||||
| PLK3 | 1263 |
| |||||||
| PMS2 | 5395 | v | v | v |
| ||||
| POLB | 5423 | v | v | v |
| ||||
| POLQ | 10721 | v | v |
| |||||
| PPA1 | 5464 |
| |||||||
| PPM1D | 8493 | v | v |
| |||||
| PRDX1 | 5052 | v | v | v |
| ||||
| PRDX4 | 10549 |
| |||||||
| PRKCB | 5579 | v |
| ||||||
| PRKCZ | 5590 | v | v |
| |||||
| PRKDC | 5591 | v | v | v |
| ||||
| PROCR | 10544 | v |
| ||||||
| PROM1 | 8842 |
| |||||||
| PSMB4 | 5692 | v | v |
| |||||
| PSMD1 | 5707 | v |
| ||||||
| PTCH1 | 5727 | v |
| ||||||
| PTEN | 5728 | v | v | v |
| ||||
| PTGS2 | 5743 | v | v | v | v |
| |||
| PTTG1 | 9232 | v | v | v |
| ||||
| RAD21 | 5885 | v | v | v | v |
| |||
| RAD23B | 5887 | v | v |
| |||||
| RAD50 | 10111 | v | v | v |
| ||||
| RAD51 | 5888 | v | v | v |
| ||||
| RAD54L | 8438 | v | v | v |
| ||||
| RAD9A | 5883 | v | v | v | v |
| |||
| RALBP1 | 10928 |
| |||||||
| RELA | 5970 | v | v | v |
| ||||
| RND1 | 27289 |
| |||||||
| RRM2 | 6241 |
| |||||||
| RRM2B | 50484 | v | v | v |
| ||||
| S100A11 | 6282 | v |
| ||||||
| SAG | 6295 |
| |||||||
| SART1 | 9092 | v | v |
| |||||
| SEC22B | 9554 |
| |||||||
| SEPHS1 | 22929 |
| |||||||
| SERPINA3 | 12 | v |
| ||||||
| SERPINE1 | 5054 | v | v | v |
| ||||
| SESN1 | 27244 | v | v | v |
| ||||
| SIRT1 | 23411 | v | v | v | v |
| |||
| SMPD1 | 6609 | v |
| ||||||
| SOD1 | 6647 | v | v | v |
| ||||
| SOD2 | 6648 | v | v | v |
| ||||
| SRC | 6714 |
| |||||||
| SRF | 6722 | v |
| ||||||
| STAT1 | 6772 | v | v | v |
| ||||
| STAT3 | 6774 | v |
| ||||||
| SUMO1 | 7341 | v | v |
| |||||
| TGFB1 | 7040 | v | v | v | v |
| |||
| TNF | 7124 | v | v | v | v |
| |||
| TNFRSF10B | 8795 | v |
| ||||||
| TNFRSF1A | 7132 | v | v |
| |||||
| TNFSF10 | 8743 | v |
| ||||||
| TNFSF9 | 8744 | v | v |
| |||||
| TOB1 | 10140 | v |
| ||||||
| TOP2A | 7153 | v | v | v |
| ||||
| TOR1AIP1 | 26092 |
| |||||||
| TP53 | 7157 | v | v | v | v | v |
| ||
| TP63 | 8626 | v | v | v | v |
| |||
| TPP2 | 7174 |
| |||||||
| TRAF2 | 7186 | v | v |
| |||||
| TRAF4 | 9618 | v | v |
| |||||
| TXN | 7295 | v |
| ||||||
| TXNRD1 | 7296 | v |
| ||||||
| UBB | 7314 | v | v |
| |||||
| UHRF1 | 29128 | v | v | v | v |
| |||
| UIMC1 | 51720 | v | v | v |
| ||||
| VEGFA | 7422 | v | v | v |
| ||||
| WRN | 7486 | v | v | v |
| ||||
| WT1 | 7490 | v | v |
| |||||
| XIAP | 331 | v | v |
| |||||
| XPC | 7508 | v | v | v |
| ||||
| XRCC1 | 7515 | v | v | [22,23,25,26,30,31,36,43,115, | |||||
| 144,145,150,154,171–175] | |||||||||
| XRCC2 | 7516 | v | v | v | v |
| |||
| XRCC3 | 7517 | v | v | [25,26,30,31,74,109,115,134, | |||||
| 144,145,172,174–176] | |||||||||
| XRCC4 | 7518 | v | v | v | v |
| |||
| XRCC5 | 7520 | v | v | v | v |
| |||
| XRCC6 | 2547 | v | v |
| |||||
| DNA-PK |
| ||||||||
| HSP70 |
| ||||||||
| MRN(95) |
| ||||||||
| RAS |
| ||||||||
Figure 1Direct protein-protein interaction network.
A network representation that illustrates the complexity of direct connections among genes identified via literature review.
The top ten GeneGo pathways/processes and GO processes resulting from genes identified via literature review.
| Ranking | GeneGo Pathways |
| 1 | DNA damage_Role of Brca1 and Brca2 in DNA repair |
| 2 | DNA damage_ATM/ATR regulation of G1/S checkpoint |
| 3 | DNA damage_NHEJ mechanisms of DSBs repair |
| 4 | DNA damage_Brca1 as a transcription regulator |
| 5 | Signal transduction_AKT signaling |
| 6 | Some pathways of EMT in cancer cells |
| 7 | Apoptosis and survival_Ceramides signaling pathway |
| 8 | Signal transduction_PTEN pathway |
| 9 | Transcription_P53 signaling pathway |
| 10 | DNA damage_ATM/ATR regulation of G2/M checkpoint |
|
|
|
| 1 | DNA damage_Checkpoint |
| 2 | DNA damage_DBS repair |
| 3 | Cell cycle_G1-S Growth factor regulation |
| 4 | DNA damage_BER-NER repair |
| 5 | Cell cycle_Meiosis |
| 6 | DNA damage_Core |
| 7 | Apoptosis_Apoptotic nucleus |
| 8 | Cell cycle_G1-S Interleukin regulation |
| 9 | Development_EMT_Regulation of epithelial-to-mesenchymal transition |
| 10 | Cell cycle_S phase |
|
|
|
| 1 | Cellular response to stimulus |
| 2 | Cellular response to stress |
| 3 | Response to stress |
| 4 | Regulation of programmed cell death |
| 5 | Regulation of cell death |
| 6 | Regulation of apoptosis |
| 7 | Response to DNA damage stimulus |
| 8 | Response to stimulus |
| 9 | DNA repair |
| 10 | Response to organic substance |
Figure 2A normal quantile plot of t-scores for GSE1977.
Significant genes have red circles.
Figure 3Significant gene detection.
A volcano plot that depicts the –log10 of q-values against log2 of fold changes for all genes in GSE1977.
Figure 4Comparison of significant genes among three sources.
A Venn diagram depicting the number of shared and unique genes among a set of genes identified by literature review and two sets of genes identified in the analysis of two gene microarray datasets.
Twenty genes commonly identified by literature review and analysis of two microarray datasets.
| Gene Symbol | Entrez ID | Gene Name |
| ACTA2 | 59 | actin, alpha 2, smooth muscle, aorta |
| BAX | 581 | BCL2-associated X protein |
| BBC3 | 27113 | BCL2 binding component 3 |
| BTG2 | 7832 | BTG family, member 2 |
| CCNG1 | 900 | cyclin G1 |
| CD70 | 970 | CD70 molecule |
| CDKN1A | 1026 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| DDB2 | 1643 | damage-specific DNA binding protein 2, 48 kDa |
| EI24 | 9538 | etoposide induced 2.4 mRNA |
| FDXR | 2232 | ferredoxin reductase |
| GADD45A | 1647 | growth arrest and DNA-damage-inducible, alpha |
| MDM2 | 4193 | Mdm2 p53 binding protein homolog (mouse) |
| MR1 | 3140 | major histocompatibility complex, class I-related |
| MYC | 4609 | v-myc myelocytomatosis viral oncogene homolog (avian) |
| PCNA | 5111 | proliferating cell nuclear antigen |
| PLK2 | 10769 | polo-like kinase 2 |
| PLK3 | 1263 | polo-like kinase 3 |
| PPM1D | 8493 | protein phosphatase, Mg2+/Mn2+ dependent, 1D |
| TNFRSF10B | 8795 | tumor necrosis factor receptor superfamily, member 10b |
| XPC | 7508 | xeroderma pigmentosum, complementation group C |
The top ten GeneGo pathways generated by MetaCore when the 20 overlapping genes were used.
| # | GeneGo Pathways |
| 1 | DNA damage_Brca1 as a transcription regulator |
| 2 | DNA damage_ATM/ATR regulation of G1/S checkpoint |
| 3 | Signal transduction_AKT signaling |
| 4 | Apoptosis and survival_Apoptotic TNF-family pathway |
| 5 | DNA damage_ATM/ATR regulation of G2/M checkpoint |
| 6 | Apoptosis and survival_p53-dependent apoptosis |
| 7 | DNA damage_Role of Brca1 and Brca2 in DNA repair |
| 8 | DNA damage_Nucleotide excision repair |
| 9 | Transcription_P53 signaling pathway |
| 10 | Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling |
Figure 5The most probable interaction network when 20 genes were entered into MetaCore software.
The resulting interacting network uses only 7 genes. Red, green, and gray lines indicate inhibitory, stimulatory, and unspecified interactions, respectively.
The results of the proposed scoring function test applied to the network in .
| Ranking | Protein | Gene symbol | Score | GSE1977 | GSE23393 | No. of edges | ||
| 1 | c-Myc | MYC | 113.74 | 0.02420 | 0.14898 | 12 | ||
| 2 | GADD45 alpha | GADD45A | 110.34 | 8.63E-06 | 0.00172 | 9 | ||
| 3 | WIP1 | PPM1D | 108.16 | 0.00044 | 0.00310 | 11 | ||
| 4 | PUMA | BBC3 | 102.70 | 0.07171 | 0.01019 | 6 | ||
| 5 | p21 | CDKN1A | 100.13 | 0.00027 | 0.00367 | 3 | ||
| 6 | PLK3 (CNK) | PLK3 | 99.70 | 0.00285 | 0.08072 | 4 | ||
| 7 | XPC | XPC | 85.62 | 0.00068 | 0.03330 | 2 | ||